NasdaqCM - Delayed Quote USD

Surrozen, Inc. (SRZNW)

0.0323 +0.0102 (+46.15%)
At close: April 24 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
12,500.0000
--
--
Operating Expense
43,028.0000
43,028.0000
56,839.0000
54,391.0000
32,807.0000
Operating Income
-43,028.0000
-43,028.0000
-44,339.0000
-54,391.0000
-32,807.0000
Net Non Operating Interest Income Expense
2,340.0000
2,340.0000
781.0000
72.0000
91.0000
Other Income Expense
-2,354.0000
-2,354.0000
7,554.0000
-329.0000
--
Pretax Income
-43,042.0000
-43,042.0000
-36,004.0000
-54,648.0000
-32,716.0000
Net Income Common Stockholders
-43,042.0000
-43,042.0000
-36,004.0000
-54,648.0000
-32,716.0000
Diluted NI Available to Com Stockholders
-43,042.0000
-43,042.0000
-36,004.0000
-54,648.0000
-32,716.0000
Total Operating Income as Reported
-45,780.0000
-45,780.0000
-44,339.0000
-54,391.0000
-32,807.0000
Total Expenses
43,028.0000
43,028.0000
56,839.0000
54,391.0000
32,807.0000
Net Income from Continuing & Discontinued Operation
-43,042.0000
-43,042.0000
-36,004.0000
-54,648.0000
-32,716.0000
Normalized Income
-40,290.0000
-40,290.0000
-36,004.0000
-54,648.0000
-32,716.0000
Interest Income
2,340.0000
2,340.0000
781.0000
72.0000
91.0000
Net Interest Income
2,340.0000
2,340.0000
781.0000
72.0000
91.0000
EBIT
-43,028.0000
-43,028.0000
-44,339.0000
-54,391.0000
-32,807.0000
EBITDA
-41,117.0000
-41,117.0000
-42,384.0000
-52,325.0000
-30,870.0000
Reconciled Depreciation
1,911.0000
1,911.0000
1,955.0000
2,066.0000
1,937.0000
Net Income from Continuing Operation Net Minority Interest
-43,042.0000
-43,042.0000
-36,004.0000
-54,648.0000
-32,716.0000
Total Unusual Items Excluding Goodwill
-2,752.0000
-2,752.0000
--
--
--
Total Unusual Items
-2,752.0000
-2,752.0000
--
--
--
Normalized EBITDA
-38,365.0000
-38,365.0000
-42,384.0000
-52,325.0000
-30,870.0000
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ESLAW Estrella Immunopharma, Inc.
0.0691
+1.02%
 
KTTAW Pasithea Therapeutics Corp.
0.0140
+12.00%
 
SABSW SAB Biotherapeutics, Inc.
0.0300
0.00%
 
NTRBW Nutriband Inc.
0.9500
0.00%
 
JSPRW Jasper Therapeutics, Inc.
0.1475
+5.51%
 
APLMW Apollomics, Inc.
0.0260
0.00%
 
ESLA Estrella Immunopharma, Inc.
1.0200
-0.97%
 
RCKTW Rocket Pharmaceuticals, Inc.
0.0990
+22.22%
 
HCWB HCW Biologics Inc.
1.3999
-5.41%
 
SABS SAB Biotherapeutics, Inc.
4.2499
+2.65%